Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

NCT: NCT03247023 · TERMINATED

NCT IDNCT03247023
StatusTERMINATED
Start Date2017-09-18
Completion2023-09-06
SponsorSmith & Nephew, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate the long term performance and safety data for the Cadence™ Total Ankle System (CTAS) when used for primary arthroplasty in patients with primary arthritis (e.g. degenerative disease), secondary arthritis (e.g. post-traumatic, avascular necrosis, if minimally 2/3 of the talus is preserved), and systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis)

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑